A*STAR Infectious Diseases (ID) Labs
LightNews LightNews
banner
astar-idlabs.bsky.social
A*STAR Infectious Diseases (ID) Labs
@astar-idlabs.bsky.social
33 followers 4 following 4 posts
A*STAR ID Labs' mission is to be a leading center of infectious diseases research excellence in antimicrobial resistance, respiratory and vector-borne diseases.
Posts Replies Media Videos
Reposted by A*STAR Infectious Diseases (ID) Labs
vignuzzilab.bsky.social
Daryl and Denzel's BIG review of antiviral resistance in light of virus evolution. These two research officers worked a lot of nights and weekends to synthesise 300 references into a topic summary.

Click here for direct access to the article:
rdcu.be/ep9Wt
Strategies and efforts in circumventing the emergence of antiviral resistance against conventional antivirals
npj Antimicrobials and Resistance - Strategies and efforts in circumventing the emergence of antiviral resistance against conventional antivirals
rdcu.be
June 9, 2025 at 1:29 PM
astar-idlabs.bsky.social
New study alert! Dr Wenn-Chyau Lee's group investigated the role of periostin (OSF-2) in the cytoadherence phenomena mediated by malaria parasites

www.frontiersin.org/journals/cel...
Frontiers | The role of periostin (OSF-2) in the cytoadherence phenomena mediated by malaria parasites
IntroductionThe pathogenesis of severe malaria is primarily attributed to the cytoadherence properties of Plasmodium-infected erythrocytes (IRBC), which incl...
www.frontiersin.org
May 13, 2025 at 7:48 AM
astar-idlabs.bsky.social
Discover the inspiring journey of Prof. Lisa F.P. Ng, Executive Director of A*STAR’s BMRC & ID Labs, in CIO Views’ IWD special edition. Her passion, leadership & dedication drive groundbreaking infectious disease research. Read more! #IWD2025
cioviews.com/lisa-ng-a-be...
Lisa Ng: A Beacon of Innovation in Biomedical Research
Curiosity often ignites the brightest minds, and for Lisa Ng, Executive Director of the Agency for Science, Technology and Research (A*STAR)’s Biomedical Research Council and A*STAR Infectious Disease...
cioviews.com
April 1, 2025 at 1:54 AM
astar-idlabs.bsky.social
Computational modelling of Mpox's airborne transmission risk. Fantastic collaboration by Dr Matthew Tay and A*STAR IHPC. medicalxpress.com/news/2025-03...
Computational model compares mpox's airborne transmission risk to COVID-19 and smallpox
A collaborative research effort between the A*STAR Infectious Diseases Labs (A*STAR IDL) and the A*STAR Institute of High Performance Computing (A*STAR IHPC) has provided new insights into the likelih...
medicalxpress.com
April 1, 2025 at 1:51 AM
Reposted by A*STAR Infectious Diseases (ID) Labs
sciencex.bsky.social
A computational model indicates that mpox's airborne transmission risk is significantly lower than that of COVID-19 and smallpox, though future viral evolution could change this dynamic. doi.org/g89m6w
Computational model compares mpox's airborne transmission risk to COVID-19 and smallpox
A collaborative research effort between the A*STAR Infectious Diseases Labs (A*STAR IDL) and the A*STAR Institute of High Performance Computing (A*STAR IHPC) has provided new insights into the likelihood of mpox spreading by airborne respiratory particles, comparing it to SARS-CoV-2 and smallpox.
medicalxpress.com
March 24, 2025 at 6:03 PM
astar-idlabs.bsky.social
Will mpox become an airborne respiratory pathogen like its now-eradicated relative, smallpox? Our researchers led by Dr Matthew Tay, in collaboration with #IHPC #A*STAR, conducted simulation modeling and found that mpox poses a much lower risk of becoming a true respiratory pathogen.
Aerosol transmission risk of mpox relative to COVID-19 and smallpox - PubMed
Aerosol transmission risk of mpox relative to COVID-19 and smallpox
pubmed.ncbi.nlm.nih.gov
February 11, 2025 at 3:47 AM